Meeting Register Page

Meet the Scientists at 4D Pharma online with the North of Scotland Research Interest Group
'Meet the Scientists at 4D Pharma PLC' online with the North of Scotland Research Interest Group

Monday 31 January, 12.30 - 2.30pm

This is one of a series of meetings on the theme of ‘the gut and Parkinson’s.' This online meeting is hosted by North of Scotland Parkinson’s Research Interest Group (NoSPRIG) and the Dundee Research Interest Group (DRIG). Presentations will feature 4D Pharma’s research and development of live biotherapeutics for treatment of neurological conditions including Parkinson’s. Opportunities for patient involvement in the planning and execution of 4D Pharma’s up and coming clinical trials will also be featured.

Session 1: ‘4D Pharma’s research on Live Biotherapeutic Products (LBPs)’
Dr Imke Mulder (Executive Vice President of Research – 4D Pharma)
Followed by Q&A

4D Pharma PLC is a Leeds-based pharmaceutical company focussed on the development of live biotherapeutic products (LBPs) from the human gut microbiome. In her presentation, Imke will give an overview of the science underpinning the production and evaluation of 4D’s live biotherapeutic drugs. Researchers in Aberdeen, working for 4D, have identified selected gut bacterial strains that diminish neuroinflammation and enhance neuroprotection in lab models systems for Parkinson’s. 4D Pharma is now planning a ‘first-in-man’ study of their LBP drugs in Parkinson’s patients.

Session 2: ‘A Patient Board to Help Shape Clinical Trials for 4D Pharma’
Louise Markinson (Program Development Director - 4D Pharma)
Eirwen Malin (Volunteer, Parkinson’s UK)
Followed by Q&A

Background: 4D Pharma has engaged with Parkinson’s UK to set up a Patient Advisory Board to help guide their upcoming clinical safety and initial efficacy trials of their live biotherapeutic products (LBPs) derived from the gut microbiome. The focus is on LBPs that via the ‘gut-brain axis’, may diminish neuroinflammation and neurodegeneration in Patients with Parkinson’s Disease. Hear more about this partnership.

Jan 31, 2022 12:30 PM in London

* Required information